Rich has been an entrepreneur, operator and investor since 1992 and is the founder of Integris, LLC, a private investment firm. Previously, Rich co- founded and served as Chairman and CEO of MedSource Technologies, Inc., a leading global provider of manufacturing and engineering services and supply chain management solutions to the medical device industry. As a founding partner of Kidd & Company, Rich participated in the development and growth of Chatham Technologies, Inc., a leading provider of custom electronic enclosure systems for the communications industry founded by the firm. Chatham grew to over $500 million in sales and 3,000 people, and was sold to Flextronics International Ltd. (NASDAQ:FLEX). Rich received a BS in Economics from the Wharton School of the University of Pennsylvania, summa cum laude, and an MBA from Harvard Business School, where he was a Baker Scholar.
CEO and Director
Eric most recently served as President of Boston Scientific’s Urology and Gynecology business, a $400 million division, where he had full P+L responsibility. His division led Boston Scientific with a 14% overall revenue growth rate while leveraging the business with a 21% increase in operating income. In his previous role Eric was in charge of the division’s New Business Development and Strategic Planning functions. He led the division’s successful entry into two new markets and developed new partnerships which were key to driving the division’s growth rate from 7% to 20%. Eric has also had a number of operations roles, running both start-up, mature and multiple production and R+D facilities for both Boston Scientific and Synthes. Eric received a B.A. from Tufts University and an M.B.A. from Harvard Business School.
Adrian joined SANUWAVE as vice president of sales and marketing in March 2006. He has remained with the veterinary business through its acquisition by PulseVet® and has been promoted to chief operating officer. Adrian’s extensive medical sales and marketing background began as a sales representative with Snowden-Pencer in 1992. After consistently achieving top sales awards Adrian was promoted into marketing management, and reached the position of marketing director with Genzyme in 1998. As director of global marketing for CryoLife, Adrian oversaw the highly successful launch of BioGlue® Surgical Adhesive in 2001. When Adrian left CryoLife to join SANUWAVE in 2006, BioGlue was globally recognized as the leading surgical adhesive used in cardiovascular surgery. Prior to entering the medical sales and marketing field, Adrian qualified as a nuclear engineer officer and served two tours aboard fast attack submarines with the United States Navy. Adrian received a bachelor’s degree from Vanderbilt University.